CORRECTION article

Front. Oncol., 13 August 2025

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1645247

Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model

  • 1. School of Pharmacy, Quanzhou Medical College, Quanzhou, Fujian, China

  • 2. Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China

  • 3. Institute of Immunotherapy, Fujian Medical University, Fuzhou, Fujian, China

  • 4. Tcelltech Biological Science and Technology Inc., Fuzhou, Fujian, China

  • 5. Public Technology Service Center, Fujian Medical University, Fuzhou, Fujian, China

  • 6. Laboratory Animal Center, Fujian Medical University, Fuzhou, Fujian, China

Article metrics

View details

1,1k

Views

275

Downloads

In the published article, there was an error in Figure 4B as published. During figure compilation, the image intended to represent the first mouse in the UTD group was erroneously placed as the third mouse in the EGFRvIII CAR group on day 7 post-tumor-cell injection, resulting in image duplication in Figure 4B. This was an unintentional error in image placement. The corrected Figure 4 and its caption appear below.

Figure 4

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

CAR-T cells, glioblastoma, IL-15, CCL19, cancer immunotherapy, EGFR vIII

Citation

Chen W, Hong L, Lin S, Xian N, Yan C, Zhao N, Xiao Y, Liao W, Huang Y and Chen M (2025) Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model. Front. Oncol. 15:1645247. doi: 10.3389/fonc.2025.1645247

Received

11 June 2025

Accepted

24 July 2025

Published

13 August 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2025

Updates

Copyright

*Correspondence: Mingzhu Chen,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics